Bronchiolitis obliterans syndrome (BOS), bronchiolitis obliterans organizing pneumonia (BOOP), and other late-onset noninfectious pulmonary complications following allogeneic hematopoietic stem cell transplantation. 2007

Satoshi Yoshihara, and Gregory Yanik, and Kenneth R Cooke, and Shin Mineishi
Division of Hematology, Department of Internal Medicine, Hyogo College of Medicine, Hyogo, Japan.

Pulmonary dysfunction is a significant complication following allogeneic hematopoietic stem cell transplantation (HSCT), and is associated with significant morbidity and mortality. Effective antimicrobial prophylaxis and treatment strategies have increased the incidence of noninfectious lung injury, which can occur in the early posttransplant period or in the months and years that follow. Late-onset noninfectious pulmonary complications are frequently encountered, but diagnostic criteria and terminology for these disorders can be confusing and therapeutic approaches are suboptimal. As a consequence, inaccurate diagnosis of these conditions may hamper the appropriate data collection, enrollment into clinical trials, and appropriate patient care. The purpose of this review is to clarify the pathogenesis and diagnostic criteria of representative conditions, such as bronchiolitis obliterans syndrome and bronchiolitis obliterans organizing pneumonia, and to discuss the appropriate diagnostic strategies and treatment options.

UI MeSH Term Description Entries
D001989 Bronchiolitis Obliterans Inflammation of the BRONCHIOLES leading to an obstructive lung disease. Bronchioles are characterized by fibrous granulation tissue with bronchial exudates in the lumens. Clinical features include a nonproductive cough and DYSPNEA. Bronchiolitis, Exudative,Bronchiolitis, Proliferative,Constrictive Bronchiolitis,Exudative Bronchiolitis,Proliferative Bronchiolitis,Bronchiolitides, Constrictive,Bronchiolitides, Exudative,Bronchiolitides, Proliferative,Bronchiolitis, Constrictive,Constrictive Bronchiolitides,Exudative Bronchiolitides,Proliferative Bronchiolitides
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013577 Syndrome A characteristic symptom complex. Symptom Cluster,Cluster, Symptom,Clusters, Symptom,Symptom Clusters,Syndromes
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor
D014184 Transplantation, Homologous Transplantation between individuals of the same species. Usually refers to genetically disparate individuals in contradistinction to isogeneic transplantation for genetically identical individuals. Transplantation, Allogeneic,Allogeneic Grafting,Allogeneic Transplantation,Allografting,Homografting,Homologous Transplantation,Grafting, Allogeneic
D018380 Hematopoietic Stem Cell Transplantation Transfer of HEMATOPOIETIC STEM CELLS from BONE MARROW or BLOOD between individuals within the same species (TRANSPLANTATION, HOMOLOGOUS) or transfer within the same individual (TRANSPLANTATION, AUTOLOGOUS). Hematopoietic stem cell transplantation has been used as an alternative to BONE MARROW TRANSPLANTATION in the treatment of a variety of neoplasms. Stem Cell Transplantation, Hematopoietic,Transplantation, Hematopoietic Stem Cell
D018549 Cryptogenic Organizing Pneumonia An interstitial lung disease of unknown etiology, occurring between 21-80 years of age. It is characterized by a dramatic onset of a "pneumonia-like" illness with cough, fever, malaise, fatigue, and weight loss. Pathological features include prominent interstitial inflammation without collagen fibrosis, diffuse fibroblastic foci, and no microscopic honeycomb change. There is excessive proliferation of granulation tissue within small airways and alveolar ducts. BOOP Bronchiolitis Obliterans Organizing Pneumonia,Bronchiolitis Obliterans Organizing Pneumonia,Primary Organizing Pneumonia,Cryptogenic Organizing Pneumonias,Organizing Pneumonia, Cryptogenic,Organizing Pneumonia, Primary,Organizing Pneumonias, Primary,Pneumonia, Cryptogenic Organizing,Pneumonia, Primary Organizing,Primary Organizing Pneumonias

Related Publications

Satoshi Yoshihara, and Gregory Yanik, and Kenneth R Cooke, and Shin Mineishi
December 2017, Clinics in chest medicine,
Satoshi Yoshihara, and Gregory Yanik, and Kenneth R Cooke, and Shin Mineishi
June 2017, Clinics in chest medicine,
Satoshi Yoshihara, and Gregory Yanik, and Kenneth R Cooke, and Shin Mineishi
November 1996, [Rinsho ketsueki] The Japanese journal of clinical hematology,
Satoshi Yoshihara, and Gregory Yanik, and Kenneth R Cooke, and Shin Mineishi
September 2001, Bone marrow transplantation,
Satoshi Yoshihara, and Gregory Yanik, and Kenneth R Cooke, and Shin Mineishi
December 2002, Pneumologie (Stuttgart, Germany),
Satoshi Yoshihara, and Gregory Yanik, and Kenneth R Cooke, and Shin Mineishi
January 1994, Ryoikibetsu shokogun shirizu,
Satoshi Yoshihara, and Gregory Yanik, and Kenneth R Cooke, and Shin Mineishi
October 1990, Singapore medical journal,
Satoshi Yoshihara, and Gregory Yanik, and Kenneth R Cooke, and Shin Mineishi
January 2002, Lijecnicki vjesnik,
Satoshi Yoshihara, and Gregory Yanik, and Kenneth R Cooke, and Shin Mineishi
January 1994, Ryoikibetsu shokogun shirizu,
Satoshi Yoshihara, and Gregory Yanik, and Kenneth R Cooke, and Shin Mineishi
October 2013, International urology and nephrology,
Copied contents to your clipboard!